FEMY
Price
$0.52
Change
-$0.05 (-8.77%)
Updated
Aug 25 closing price
Capitalization
16.78M
72 days until earnings call
NYXH
Price
$6.46
Change
+$0.02 (+0.31%)
Updated
Aug 25 closing price
Capitalization
249.7M
79 days until earnings call
Interact to see
Advertisement

FEMY vs NYXH

Header iconFEMY vs NYXH Comparison
Open Charts FEMY vs NYXHBanner chart's image
Femasys
Price$0.52
Change-$0.05 (-8.77%)
Volume$1.13M
Capitalization16.78M
Nyxoah SA
Price$6.46
Change+$0.02 (+0.31%)
Volume$69K
Capitalization249.7M
FEMY vs NYXH Comparison Chart in %
Loading...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FEMY vs. NYXH commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMY is a Buy and NYXH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (FEMY: $0.52 vs. NYXH: $6.45)
Brand notoriety: FEMY and NYXH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: FEMY: 297% vs. NYXH: 72%
Market capitalization -- FEMY: $16.78M vs. NYXH: $249.7M
FEMY [@Pharmaceuticals: Other] is valued at $16.78M. NYXH’s [@Pharmaceuticals: Other] market capitalization is $249.7M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.92B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FEMY’s FA Score shows that 0 FA rating(s) are green whileNYXH’s FA Score has 0 green FA rating(s).

  • FEMY’s FA Score: 0 green, 5 red.
  • NYXH’s FA Score: 0 green, 5 red.
According to our system of comparison, both FEMY and NYXH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FEMY’s TA Score shows that 3 TA indicator(s) are bullish while NYXH’s TA Score has 4 bullish TA indicator(s).

  • FEMY’s TA Score: 3 bullish, 5 bearish.
  • NYXH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NYXH is a better buy in the short-term than FEMY.

Price Growth

FEMY (@Pharmaceuticals: Other) experienced а -26.42% price change this week, while NYXH (@Pharmaceuticals: Other) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.61%. For the same industry, the average monthly price growth was +2.14%, and the average quarterly price growth was +19.48%.

Reported Earning Dates

FEMY is expected to report earnings on Nov 06, 2025.

NYXH is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NYXH($250M) has a higher market cap than FEMY($16.8M). NYXH YTD gains are higher at: -19.313 vs. FEMY (-53.173). FEMY has higher annual earnings (EBITDA): -18.34M vs. NYXH (-64.3M). NYXH has more cash in the bank: 63M vs. FEMY (3.22M). FEMY has less debt than NYXH: FEMY (7.85M) vs NYXH (22.1M). NYXH has higher revenues than FEMY: NYXH (4.36M) vs FEMY (1.89M).
FEMYNYXHFEMY / NYXH
Capitalization16.8M250M7%
EBITDA-18.34M-64.3M29%
Gain YTD-53.173-19.313275%
P/E RatioN/AN/A-
Revenue1.89M4.36M43%
Total Cash3.22M63M5%
Total Debt7.85M22.1M36%
TECHNICAL ANALYSIS
Technical Analysis
FEMYNYXH
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CALX58.810.35
+0.60%
CALIX
NAGE10.030.05
+0.50%
Niagen Bioscience Inc
MCRB19.23-0.21
-1.08%
Seres Therapeutics Inc
WEC106.96-1.58
-1.46%
WEC Energy Group
LPCN3.02-0.09
-2.89%
Lipocine

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-9.79%
OFIX - FEMY
30%
Poorly correlated
-0.34%
CSTL - FEMY
30%
Poorly correlated
-1.30%
LUCD - FEMY
30%
Poorly correlated
+5.45%
OM - FEMY
29%
Poorly correlated
-3.38%
GH - FEMY
29%
Poorly correlated
+0.78%
More